KR Choksey is bullish on Zydus Lifesciences has recommended buy rating on the stock with a target price of Rs 1201 in its ...

Sonos reported mixed first-quarter fiscal 2025 results, with revenue and earnings per share beating expectations despite revenue falling year over year.

Luxembourg, 06 February 2025 – Novem Group S.A. today published its figures for the third quarter of its financial year 2024/25. In the first nine months of financial year, Novem generated a total ...

Blue Bird Reports Fiscal 2025 First Quarter Results; Beats First Quarter Guidance; Reaffirms 2025 Guidance and Long-Term ...

Net sales of $521 million (+2% actual rates, +4% constant exchange rates (CER) core growth); diluted EPS of $0.39 and ...

但是，在核心投资逻辑受到自动驾驶威胁 & 当前对应 26 年 20x 以上 PE 这并不算便宜的估值下，市场对 Uber ...

KR Choksey recommended accumulate rating on Divis Laboratories with a target price of Rs 6435 in its research report dated ...

C.H. Robinson’s solid profit growth contrasts with weak overall revenue. Read why CHRW stock remains a hold amid global ...

CENTENNIAL, CO / ACCESS Newswire / January 31, 2025 / NioCorp Developments Ltd. ("NioCorp" or the "Company") (NASDAQ:NB) today announced the closing of its previously announced underwritten offering ...

Tesla (NASDAQ:TSLA) stock surged nearly 4% on Thursday, as investors looked beyond a weak 4Q24 earnings report and focused on ...

ResMed reported robust earnings for the second quarter of fiscal 2025, surpassing expectations and showcasing strong growth in revenue and profitability.

Despite cost-cutting and acquisitions by Xerox, margins remain under pressure, with gross margin falling. Read why I maintain ...